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The most remarkable histologic feature
produced

in response

mononuclear cells,
is

true of

to a viral infection is

the

inflammatory reaction

localized accumulation of
and macrophages.

This

the perivascular cuffing described for viral pneumonias or

to vaccinia.

are doing,

the

usually identified as lymphocytes

encephalitides as well as
reaction

of

the more diffuse but still localized dermal

Yet surprisingly little is known about what these cells

especially when contrasted to

neutrophiles

in the inflammatory response

the well defined functions of
to bacterial infection.

Virus-

induced lesions are histologically similar to those of delayed hyper¬
sensitivity reactions;

however,

until recently,

little had been added

to

this otherwise superficial relationship.
Recent developments

in immunology,

virology,

and cell culture

techniques have made possible

the study of reactions

well defined cell populations

in response to viral stimuli.

identification,

by

Isaacs

produced in response

and Lindenmann in 1958,

aroused in the biochemistry of

special interest was

(32),

inhibiting virus

a great surge of interest

cellular responses

the observation that

With the

of a protein substance

to viral infections and capable of

multiplication and virus-induced cell damage
was

and interactions of

to viruses.

Of

this protein, now called interferon.

2.
acted on

the susceptible cell

rather than on the virus itself,

as does

antibody.
Concomitantly,

immunologists were becoming increasingly aware of the

versatility of the lymphocyte which,
stimuli by
other cells

they found,

could respond

to various

the production of proteins capable of causing striking changes
(3).

in

The old distinction between cellular and humoral immunity

and the histologic changes accompanying each could now be viewed as
resulting from the qualitatively different
response

to exogenous stimuli.

sensitivity have
products

products produced by cells

The cellular products

While the importance of

conventional immune

interferon in recovery from viral infections
the role of the more

responses has been largely neglected or dismissed

the

roles of interferon,

subject have considered and contrasted
antibody,

entirely separable entities.
individual investigators,
the three responses and,
differences

the cellular

their primary action on the stimulus itself

has justifiably gained wide and rapid acceptance,

Recent reviews of

in delayed hyper¬

their primary action on other cells, whereas

in humoral immunity have

in

(2,

29)

the relative

and delayed hypersensitivity as

if they were

Reflecting the experimental questions asked by

these reviews have emphasized
from these differences,

the differences in

have extrapolated to

in significance.

This thesis presents experimental evidence linking interferon
production

to delayed hypersensitivity and reinterprets some of

preexisting data.

It emphasizes

the relevant

the immunologic rather than the non-

immunologic aspects of interferon production,

and aims

toward a more unified

and comprehensive mechanism for recovery from viral infections.

3.

A.

INTERFERON

General Properties
Available evidence indicates

that

interferon is a protein with the

ability to inhibit viral multiplication intracellularly

(37).

It has a

molecular weight of 25,000-100,000,

is stable over the pH range 1-10,

slowly loses

titer at

at -20°C.

nonspecific;

to varying degrees it will inhibit multiplication of virtually

all animal viruses.

37°C.

but not

Its effectiveness

Its anti-viral effect is

is species specific;

effect is best or solely demonstrated in cells

and

its anti-viral

or animals of the species

from which it was derived.

_2.

Methods of

Induct ion

Interferon can be isolated from the serum or organs of many different
animals infected with RNA or DNA viruses.

The in vitro production of

interferon has been observed in cell lines

from species as diverse as

and man

(7).

Differences

in the ability of different

interferon have remained unexplained.

Likewise,

cells

fish

to produce

it is not known why some

viruses are better inducers of interferon than others.

In most mouse cells,

arboviruses have been good inducers of interferon.
The mechanism of

interferon induction and

the

characteristics of

interferon produced seem to vary according to the nature of the
agent.

One class of inducers

hypothesis is
interferon
which are

that

(15).
thought

initiate its

is

they derepress
Endotoxin is

the viruses;

inducing

the currently accepted

a host cell gene which codes

for

the prototype of another class of inducers

to cause the release of

de novo synthesis

the

(30,

31).

"preformed1' interferon rather than

4.
It has been shown
are reached much more
interferon

(31).

that peak titers of endotoxin-induced

interferon

rapidly than peak titers of virus induced

Also,

in vivo concentrations of actinomycin D sufficient

to inhibit virus-induced interferon production do not inhibit endotoxininduced interferon production

(31).

The validity of using these observations

as

the basis

for making a

mechanistic distinction between classes of inducers may be questioned.
Many attempts

to induce interferon with endotoxin In vitro have failed,

and

the endotoxin experiments which use inhibitors of ENA and protein synthesis
have been done rn vivo.

Recently,

Smith and Wagner reported _in vitro

endotoxin-induced interferon production in purified rabbit macrophages
They found that

induction by

this method was

(46).

inhibited by actinomycin D.

Sauter and Gifford measured in vivo levels of interferon and a lysosomal
enzyme following intravenous administration of endotoxin and found that both
reached maximum titers at

two hours

may be released from lysosomes.

(43).

They concluded that interferon

Another interpretation is that

increases cell membrane permeability to proteins,

interferon

thereby allowing interferon

to escape more rapidly than it does with virus-inducers.
Endotoxin-induced interferon has
physical characteristics

also been observed

from virus-induced interferon.

have a greater molecular weight

(30)

it is difficult

is reported to

and to be less heat and acid stable

than virus-induced interferon from the same animals
can be purified,

It

to have different

(31).

Until interferon

to know the significance of these

observations.
Other aspects of endotoxin-induced interferon must be considered by
any investigator working with culture media that may contain pyrogen.

Two

5.
investigators have demonstrated _in vitro interferon production induced by
endotoxin;

in one case,

anti-endotoxin antibody enhanced the response

Tolerance,

or the inability of animals or cells

variable period after injection of virus
in vitro significance.

For instance,

(46,

6).

to make interferon for a

or endotoxin, may prove to have

some cells are unable to produce

interferon in response to viruses if they are cultured for several hours
before challenge

(5,

53).

Conceivably,

this phenomenon could be due

to

tolerance induced by endotoxin present in the media.

3.

Mechanism of Action
The mechanism of action of interferon is unknown.

not directly inactivate virus particles or
it affect virus

adsorption,

penetration,

Interferon does

infectious nucleic acid, nor does

or uncoating.

It does not appear

to inhibit host cell protein synthesis or the activity of specific viral
enzymes

(45).
Studies with antimetabolites have shown that host cell DNA-dependent

RNA synthesis and protein synthesis are necessary for interferon action.
The hypothesis

that interferon acts as a derepressor for the synthesis of

another cellular protein, which may act in conjunction with interferon or
may be the anti-viral molecule itself,
experimental data.

Recent evidence,

attention on the ribosome as

consistent with available

reviewed by Vilcek,

has focused

the site of anti-viral action

As with interferon induction,
different cells or viruses

is

(50).

variability in the responsiveness of

to the action of interferon is a frequently

observed but poorly understood phenomenon.

Vesicular stomatitis virus and

mouse L cells have been widely used as an assay system for mouse interferon.

.

6
Even with this system,

however, different sensitivities have been reported

for different clones of cells and mutants of the virus (36).

B.

INTERFERON PRODUCTION BY LYMPHOCYTES AND MACROPHAGES
Lymphocytes and macrophages have been shown to produce interferon

in vitro and indirect evidence implies that they are also important in vivo
sources of interferon (13, 28, 35, 46,

53).

The most convincing Tn vivo evidence has been presented by DeMaeyer
et al, who irradiated C^H/He mice with 1000 rads,
with Wistar rat marrow cells,
Newcastle Disease Virus

(13).

restored their bone marrow

and three weeks later challenged them with
Whereas unrestored irradiated animals

produced no detectable circulating interferon in response to the challenge,
animals restored with rat cells produced interferon proportional to the rate
of marrow repopulation and having the specificity of rat interferon.
In vitro studies designed to elucidate which of the bone marrowderived cells produce interferon show that both macrophages and lymphocytes
produce interferon.
generalization.

However,

the details of the experiments caution against

Rabbit macrophages produce interferon in response to viruses

and purified endotoxin (46), whereas mouse macrophages respond to viruses but
not endotoxin (48).

It is not known whether this represents a relative or

absolute species insensitivity to endotoxin.

Studies with lymphocytes

indicate that these cells make interferon in response to viruses, phyto¬
hemagglutinin, pokeweek mitogen, and streptolysin 0 (20, 28, 53).

These

experiments with lymphocytes all used human blood cells and, although
attempts were made in two cases to purify the cells,

the reports lacked a

critical evaluation of the purification procedures.

Because of this, some

.

7
doubt must remain as
interferon,
maintain

but

to which cell type in those preparations produced

the

the burden of proof now seems to fall on those who would

that lymphocytes do not produce interferon.

The methods

of collection and culture of cells

interferon production.
were cultured

for more

Wheelock observed that if his purified lymphocytes
than

two hours before challenge with NDV they lost

their ability to produce interferon
if PHA was

the inducer.

can influence

(53).

This was not,

Smith and Wagner found

media contained pyrogen and

however,

observed

that all of their culture

that cultures of uninfected rabbit macrophages

produced low titers of interferon

(46).

cavities stimulated with glass beads

Also, macrophages

from peritoneal

72 hours before collection produced

far more baseline interferon than macrophages from unstimulated peritoneal
exudate.

The authors suggest

can partially activate

C.

that nonspecific mobilization of macrophages

them to produce interferon.

DELAYED HYPERSENSITIVITY

1_.

In Vivo
Delayed hypersensitivity is

characteristic pathological changes
histologic features
accumulations

of this

the capacity of animals to manifest
in response to antigenic stimuli.

reaction to antigen are perivascular and tissue

of lymphocytes and macrophages followed by widely varying

degrees of tissue necrosis,

fibrinoid necrosis of blood vessels,

accumulation of polymorphonuclear leucocytes

(51).

characteristics of delayed hypersensitivity are its
and its

The

requirement

for specific lymphoid cells

and

The chief operational
immunologic specificity

rather than humoral antibody.

.
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On the basis of similar histologic
requirements,

features

and

such seemingly diverse entities

contact allergy,

and homograft

rejection

the above mentioned operational

as tuberculin skin sensitivity,

can all be termed delayed hyper¬

sensitivity reactions.

_2.

_In Vitro
Studies of lymphocytes in vitro have greatly aided

of the mechanism whereby

these cells effect

the presence of antigen,

the understanding

the pathological changes

observed.

In

sensitized

to that antigen have been shown to release several biologically

active molecules

(all

lymphocytes

from animals

tentatively identified as proteins).

These include a

factor which inhibits macrophage migration

(4,

cytotoxic for a variety of cells

a factor which is chemotactic for

(42,

25),

12),

specifically

a factor which is

macrophages

(52),

a factor which induces blast

transformation in

lymphocytes

(17),

and a factor which transfers delayed

skin reactivity

(34).

Normal lymphocytes will respond to mitogens by producing some of the above
factors and,

in addition,

interferon

with these other proteins is unknown.

(3).

Why interferon is found

Furthermore,

that a single protein may possess the properties
mentioned

_3.

in consort

the possibility exists

of several of the above

factors.

Jn Mice
Most demonstrations of delayed hypersensitivity in mice have been

indirect

(increased

unconvincing

(11,

susceptibility to endotoxin shock)

1),

or

except when replicating antigens such as live

Mycobacterium hominis have been used
clarified

(26)

(14).

Kantor recently reviewed and

the problem by testing 25 mouse species

for delayed hypersensitivity

.

9
to heat killed Mycobacterium

(33).

He found marked species variability to

footpad injections of PPD and showed
reactors.

Gross measurement of the

of the histologic lesions.

that BALB/c and C^H mice were the best
feet correlated well with the severity

The delayed hypersensitivity could be transferred

to normal mice with peritoneal exudate cells but not with spleen or lymph
node cells.

A*

Virus

Infections

The histologic changes

seen in virus infections are frequently

indistinguishable from those seen in delayed hypersensitivity reactions.
Whether these changes
or are

represent an immunologic

reaction

to viral antigens

the nonspecific consequence of direct cell damage caused by the

virus is unknown.

There is

some experimental evidence,

interpretations of

"experiments

as well as

of nature," that suggest a role

for delayed

hypersensitivity in virus infections.
People with agammaglobulinemia in whom there is no deficiency in
cellular or delayed immunity,
the usual way

as evidenced by their ability to react in

to skin grafts or skin tests for delayed hypersensitivity,

have no difficulty recovering from most viral infections.

In contrast,

people with congenital deficiencies in their ability to develop delayed
reactions often die in childhood from viral
Experimentally,

(22).

(44).

peritoneal cells, but not serum,

infected with fibroma virus
animals

illnesses

from animals

confer partial resistance to fibroma in other

The macrophage migration inhibition experiment,

George and Vaughn

(21)

hypersensitivity,

also works using cells

described by

and interpreted as an rn vitro manifestation of delayed
from mice immunized with mumps and

.
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influenza viruses

(16).

Newborn rabbits,

the injection of heat killed virus,
when challenged several days
animals
the

died

(18).

and

vaccinia in newborn rabbits,

only a minimal local

was due

others have shown that guinea pigs made

recovered from vaccinia infections as

treatment with methotrexate

rapidly as controls,

to give delayed skin reactions

Furthermore,

but were

to heat-killed

the amount of interferon found

in homogenates

of primary skin lesions was equal in immunologically paralyzed and
control animals.
was

These results were interpreted as showing that

responsible for

in

to delayed-type hypersensitivity.

immunologically unresponsive by x-irradiation and

(19).

lesion was found

as well as the prevention of generalized

Using a different approach,

vaccinia

none of the control

the investigators cautiously suggested that the

skin lesion of primary vaccinia,

subsequently unable

to vaccinia by

developed progressively lethal vaccinia

later with live virus;

Interestingly,

tolerant animals

rendered tolerant

the recovery from viral

infections

hypersensitivity and antibody played little,

if any,

and

role.

have been far more convincing if it had demonstrated that
unresponsive" animals also failed

to react

to more

in

interferon

that delayed
This work would
the "immunologically

typical delayed hyper¬

sensitivity-evoking stimuli.

_5.

Acquired Cellular Resistance
Animals infected with intracellularly replicating bacteria develop

both an immunologically specific and nonspecific ability to resist
reinfection

(38).

Macrophages

from such animals have an increased capacity

to destroy ingested microorganisms,
antibody.

Macrophages are

thus

even in the absence of conventional

thought

to be the effector cell

for the

.

11
in vivo phenomenon called acquired cellular resistance.
believed to be the result

of nonspecific activation of macrophages

to specific lymphocyte-antigen interaction.
bacteria,

fungi,

secondary

It has been observed with

and protozoa and correlates well with increased macrophage

production of lysosomal enzymes
used

Such resistance is

to explain the

(38).

Acquired cellular resistance has been

fibroma virus experiment mentioned above as well as

other demonstrations of decreased virus replication after reinfection
It adds little,

however,

to the understanding of

these virus experiments unless

it.

(47).

the mechanisms involved in

can be distinguished from or correlated

with known immune reactions and/or interferon.
Animals

displaying acquired cellular resistance also commonly have

delayed hypersensitivity to the infecting organism.

The relationship

between these two altered states of reactivity is unknown,
possibilities have been suggested

(39):

[1]

but two

sensitized lymphocytes

react

with antigen and produce a pharmacologically active substance which in turn
causes

changes in macrophages;

[2]

sensitized lymphocytes react with antigen

and produce a cytophilic antibody which,

when combined with antigen,

causes

changes in macrophages.

D.

EFFECT OF IMMUNITY ON INTERFERON PRODUCTION
Animals making interferon in response to a virus develop immunity

(cellular or humoral or both)

to that virus.

How immunity affects or relates

to interferon production was the subject of experiments
Glasgow
virus

(23).

Peritoneal cells

from CD-I mice immunized against Chikungunya

(CV) were challenged in vitro with live CV.

for interferon showed that cells

reported by

Culture fluids assayed

from immune animals produced two

to ten

.

12
times more interferon
specific

for CV;

than cells

other viruses

from control animals.

did not produce

This increase was

the effect

in CV immune cells.

It was also shown that the rate of adsorption of CV was equal in control and
CV immune cells;

that virus neutralized with antibody resulted in a poor but

equal response in both normal and
to anti-CV antibody and
response to CV as
that

immune cells;

and

that normal cells exposed

then washed produced nearly as much interferon in

cells not exposed to antibody.

Glasgow’s conclusion was

the enhanced interferon production by immune cells provided a mechanism

whereby cellular immunity could influence viral infections.
*

*

The work to be described in this
and extend Glasgow's

observations.

*

thesis was undertaken to confirm

Of special interest were the relative

roles of macrophages and lymphocytes in the enhanced response observed with
crude peritoneal exudate cells.

Experiments were designed to test

two

theoretical interpretations of Glasgow’s results:
1.

If increased interferon production is analogous to acquired

cellular resistance, macrophages should be the important effector cell.
It might also be expected that lymphocytes

are important in making the

reaction immunologically specific.
2.

If the increased interferon production is a manifestation of a

delayed hypersensitivity reaction,

then other in vitro examples of delayed

hypersensitivity reactions should yield the same result.

.
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MATERIALS AND METHODS

A. MICE
Random-bred six week old male Swiss
by the Division of Animal
viruses and

from a colony maintained

Care at Yale, were used for all experiments with

for the initial experiments with tuberculin-sensitized animals.

Inbred six week old male BALB/c mice,
Harbor,

ICR mice,

obtained

from Jackson Farms,

Bar

Maine, were used for the definitive studies with tuberculin-

sensitized animals.

B.

CONTINUOUS LINE CELL CULTURE
L cells

a gift

(clone 929),

from Dr.

Appendix)

Hilton B.

in 250 ml.

an established line of mouse fibroblasts, were

Levy.

Cells were grown in growth medium (see

screw-top plastic flasks

gassed with a mixture of 5% ^2^95% air.
decanting the

growth medium,

incubating for five minutes
versene
week,

(1:10,000)

mixture.

depending on

the need

contaminants

C.

(Falcon Plastics) which were

Cells were

transferred by

washing the cell sheet with Saline A,
at 37°C.

with 0.5 ml.

Cells were split and
for them.

Attempts

of a trypsin

and

(0.125%):

transferred 1-2

times per

to isolate possible mycoplasma

from these cells and culture media were negative.

VIRUSES
All viruses were obtained

from the W.H.0.

Laboratory of the Yale Arbovirus Research Unit. ■
virus

(CV,

Arbovirus Reference
Two pools of Chikungunya

175th baby mouse brain passage) were prepared by intracerebral

inoculation of three day old mice with 0.02

ml.

of the 10% virus

.
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preparation reconstituted with PBS.

Two days after infection,

dying mice were aseptically removed with scissors and forceps,

the brains of
made into a

10% suspension in PBS by repeated passage through a 20 guage needle,
centrifuged for 20 minutes at 10,000 r.p.m.
refrigerated centrifuge.
ampoules,

of Hg.

stored at -70°C.

and vacuum desiccated for six

The ampoules were then filled with

in a Revco freezer.

for at least three months.

of LD^q=10

^‘^-lO ^’0/0.02 ml.

(E.G.,

(VSV),

for CV except that it was suspended
(WN) was

sealed,

and

These preparations maintained their
Pool 1 had an intracerebral

Indiana strain,

baby mouse brain passage, was prepared in pools

West Nile virus

,

titer

in suckling mice.)

Vesicular Stomatitis Virus

D.

in a Sorvall RC-2

of the supernatant, were placed in

shell-frozen in dry ice-ethanol,

hours at lm

titers

Aliquots

(12,350 g)

and

from the eighth

in a manner similar to that

in PBS + 0.75% bovine albumin.

from the eleventh baby mouse brain passage.

METHODS OF SENSITIZATION

1.

Virus
Groups of 20-30 six week old Swiss ICR mice were immunized by three

weekly intraperitoneal injections of 0.1 ml.

of live Chickungunya virus,

rehydrated from the lyophilized form to a 10 ^ dilution with sterile PBS.
An equal number of animals injected intraperitoneally with 0.1 ml.
suspension of baby mouse brain
weeks after the last injection,
testing of

(BMB)

served as controls.

of a 10%

Three to twelve

the animals were sacrificed

for in vitro

their peritoneal cells.

One group of animals was immunized as above except

that

the virus

15.
suspension was emulsified with an equal volume of Freund's
adjuvant

(85% Bayol F,

15% Arlacel A).

Another group of animals was
given in each of

three

incomplete

footpads.

immunized by 0.033 ml.

This group

of live CV

(10

received two such injections

and was sacrificed three weeks after the last injection.
An average of one animal per group died before sacrifice.

2_.

Mycobacterium Tuberculosis

(MT)

Mycobacterium tuberculosis hominis,
killed, washed,
Both Swiss

strains

C,

DT,

and PN, heat

and dried on 9/24/58, were obtained from Dr.

Byron Waksman.

ICR and BALB/c mice were immunized with MT.

Groups of 40-50 six week old mice were anesthetized with ether and
injected in each of three
Bayol F

(1 mg./ml.).

footpads with 0.033 ml.

Each animal

animals were either sacrificed
or were

E.

thus

of MT suspended in

received 100yg.

for iai vitro testing of

of MT.

their peritoneal cells

footpad tested with PPD.

FOOTPAD TESTING
Animals were anesthetized with ether and tested in

had not been used for immunization
25

yg.

later,
the

Control

PPD

(Parke,

Davis

& Co.)

ten days previously.

in 0.05 ml.

the animals were killed and

PPD diluent.

the
The

footpad which
test dose was

Twenty-four hours

the largest dorsal-ventral diameter of

footpad was measured with a vernier caliper.

.
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F.

IN VITRO CULTURE OF MOUSE PERITONEAL CELLS

jl.

Crude Peritoneal Exudate
Mice were rapidly killed with ether.

with

70% ethanol and reflected.

aseptically.

cavity.

All further manipulations were done

With a Pasteur pipette,

exudate harvesting medium

1 1/2 - 2 ml.

fluid was withdrawn,

and centrifuged for five minutes at 900
The

flasks

counted and

(Falcon Plastics)

in a final volume of 4 ml.
C02:95% air,
2-4x10^

.

2

r.p.m.

(see Appendix)

peritoneal

in a refrigerated
carefully and

resuspended in
by gentle pipetting.

distributed to 75 ml.

2

(25 mm )

plastic

so that each flask contained 5x10^ cells

maintenance medium.

tightly capped,

(300 g)

and the cells were

peritoneal exudate maintenance medium

screw-top

(4°C.)

using a Pasteur pipette,

resulting supernatant was

thoroughly removed by aspiration,

The cells were

of cold

(see Appendix) was introduced into the peritoneal

Ten minutes later the

International Centrifuge.

The abdominal skin was washed

Flasks were gassed with 5%

and incubated at 37°C.

Each mouse yielded

cells.

Purified Macrophage Preparation
Crude peritoneal exudate was prepared as above.

placed in each

flask and,

after incubation

10^ cells were

for one hour at 37°C., non¬

adherent cells were removed by gentle agitation and aspiration.
cells were washed

two times with maintenance medium.

cells remained adherent after washing and
macrophages

(see below).

Adherent

Approximately 5-6x10

these were predominantly

.

17
_3.

Purified Lymphocyte Preparation
The non-adherent cells

from

the first aspirate of

the crude peritoneal

exudate preparation which had been allowed to incubate for one hour at 37°C.
were predominantly lymphocytes.
one hour incubation at 37°C.

They could be

Approximately 3-4x10^ non-adherent cells could

be recovered after the second adsorption,
lymphocytes

G.

further purified by another

and

these were predominantly

(see below).

CELL STAINING AND ENUMERATION

1_.

Counting
Cells were diluted in Turk’s solution

violet)

2_.

(3% acetic acid,

1% crystal

and counted in a Beckman hemocytometer.

Gi ems a
Using a Giemsa stain of mouse peritoneal cells prepared

similar to that described above,

Cohn reported that 50-60% of the crude

exudate cells were macrophages while the rest were lymphocytes
trying to duplicate

in a manner

(9).

that observation using a standard Giemsa stain,

In
it was

found that approximately 50% of the cells were easily identified as
macrophages

and 30% as lymphocytes,

poorly stained,
cell

(<1%)

while the remaining 20% were either

smudged or otherwise indistinguishable.

An occasional mast

and a very occasional polymorphonuclear neutrophile

(<<1%)

were seen.

3.

Carbon Ingestion
A physiologic differentiation of

the

two

types of cells was therefore

.
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attempted.

Crude peritoneal exudate and purified preparations of

"macrophages" and "lymphocytes" were prepared in Leighton tubes with coverslips cut from the plastic bottoms of Falcon flasks.
then incubated for one hour at 37°C.
1:10,000.
97% of

with carbon

Each preparation was

(Pelikan cH/1^31^

^.Quted

Microscopic examination showed that 63% of the crude exudate cells,

the "macrophage" preparation,

ingested carbon particles

(>5/cell).

and 7% of the "lymphocyte" preparation
It should be noted that these

"purified" cell populations did not have the extra adsorption and washing
steps used subsequently in preparing cells

A*

for experiments.

Viability
Cell viability was determined using the trypan blue exclusion

technique.

Cells were exposed to a 1:5 dilution of 0.4% trypan blue

(Allied Chemical)

for five minutes

and examined microscopically.

preparations of crude peritoneal exudate, macrophages,
average of 99%,

H.

93% and 96% of the cells,

respectively,

In

and lymphocytes,

an

excluded the dye.

INTERFERON PRODUCTION IN VITRO
Cells

to be tested

for their ability to produce interferon were

prepared in plastic flasks as described above.
duplicate

In virus experiments,

cultures of cells from CV immune animals and BMB immune animals

received 0.5 ml.

CV

maintenance medium).

(10 ^ dilution of the mouse brain preparation in
In most experiments CV immune

10% BMB had been added,

served as a control.

gassed and incubated 24 hours
interferon.

at 37°C.,

cells,

to which 0.5 ml.

After preparations were

the culture medium was assayed for

.
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In experiments with tuberculin sensitized cells, 25 yg./ml. PPD was
added to the culture medium,
24 hours at 37°C.

1.

the flasks were gassed, and then incubated for

Control preparations are described in Results.

INTERFERON ASSAY

_1.

Preparation of Samples
Preparations to be assayed for interferon were clarified by

centrifugation for 20 minutes at 10,000 r.p.m.
Sorvall.

(12, 350 g)

in the refrigerated

In the experiments where PPD was the interferon inducer,

the

clarified supernatant was assayed directly.
When live virus was used as the interferon inducer, it had to be
killed before the preparations could be assayed.

This was achieved by

aseptically pipetting the clarified preparation into 5/8 inch diameter
dialysis tubing (Arthur H.

Thomas Company) which had been knotted at one

end and autoclaved in distilled water for 15 minutes.

The other end of the

tubing was then sealed with another knot and suspended by a string from the
lip of an Erlenmeyer flask.

The fluid in the tubing was dialyzed for 24

hours at 4°C.

against 20-30 volumes (as compared to the total volume of the

preparations)

of HC1, pH 2.0, and then neutralized by a six hour dialysis

against ten volumes of Saline A.

All preparations were stored at -40PC.

A laboratory interferon standard was prepared from the brains of
five week old male mice which had been intracerebrally infected with 0.1 ml.
West Nile virus diluted 10

-4

.

Three days after infection a 20% brain

suspension in PBS was made from those animals and treated as above for
virus-induced interferon preparations.

The West Nile preparation maintained

.
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a constant titer for more than six months when stored at -40°C.

_2.

The Assay
Interferon activity was assayed by the plaque reduction method using

L cells and Vesicular Stomatitis Virus.

Interferon preparations were

diluted by serial 2- or 4-fold dilutions in diluent
VSV was

diluted with cold diluent so that 0.2 ml.

(see Appendix)

at 37°C.

of the final dilution

£
would contain approximately 30-50 plaque forming units.
8-10 ml.
plates

1.5x10

L cells in

of growth medium were pipetted into six cm. multiwell plastic

(Linbro FB6-TC)

atmosphere.
monolayer,

In two to three days, when

in a humidified 5% CO^

the cell sheet was a confluent

the growth medium was removed and two ml.

preparation was
incubation

and incubated at 37°C.

added and allowed to incubate at 37°C.

time in most experiments was

preparations were then removed,
of warm PBS,
hour at 37°C.
agar overlay

of the

and 0.2 ml.

six hours.

interferon

for 3-20 hours.

The interferon

the cell sheet was washed once with five ml.

VSV was dropped onto the cells and incubated one

The cell sheets were then overlaid with five ml.
(see Appendix)

second agar overlay

The

and returned,

(see Appendix) was

inverted,

of the first

to the incubator.

applied at 24-40 hours and

The

the plaques

were counted at 40-48 hours.

_3.

Variability
The variability in the

triplicate platings of the sample dilutions

is somewhat greater than that usually acceptable
techniques.

in standard virus plaquing

Similar variability is present, however,

literature in which actual plaque counts were reported
the most

likely source

in the early interferon
(19).

In retrospect,

for the variability in the plaquing reported here is

.
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in the method used to prepare the cell sheets.
pipetted

in 0.5 ml.

amounts

into the dishes containing growth medium.

better method would have been to dilute
growth medium,

the

that

comparable samples are significant,

A

cells in the total volume of

thereby allowing larger volumes

the variability, _t tests reveal

are not.

Aliquots of cells were

to be pipetted.

In spite of

the differences between some of the
while

the differences between others

.
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RESULTS

A.

INTERFERON PRODUCTION BY CELLS FROM TUBERCULIN SENSITIZED ANIMALS
Preliminary studies with peritoneal cells

from ICR mice immunized

with MT showed interferon production i_n vitro proportional to the amount of
PPD added.

Since PPD in concentrations greater than 50 yg./ml.

be cytotoxic,

all further experiments used PPD at a concentration of 25

The results of two early experiments,
suggested

that

the presence

is known to

the cells

than in

yg./ml.

although not statistically significant,

from immunized animals produced more interferon in

the absence of PPD,

and that

cells from control animals

did not respond in that manner.
Kantor has
ability

shown that different strains of mice vary greatly in their

to exhibit

tuberculin sensitivity,

the best responders
the experiments

(33).

Table

BALB/c mice were,

to be described,

was assessed by footpad

and

testing.

and

that BALB/c mice are among

therefore,

used in the rest of

their delayed hypersensitivity to PPD

The results of such a test are shown in

1.
Medium from the incubation of crude peritoneal exudate cells with and

without PPD was assayed for interferon.
and Figures
interferon

1 and 2,

whereas cells

interferon production.
test done on

in the presence of PPD than

from control animals

Table 2 also shows

these differences.

it was necessary to make

show no difference in

the results of a significance

Since it had been found that PPD affected

titration by increasing the number of plaques

of VSV,

summarized in Table 2

show that cells from immune animals produced more

(as evidenced by plaque inhibition)

in its absence,

the

The results,

formed by a given amount

the raw data comparable before calculating

.
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the _t values.

This was done by multiplying the number of plaques

PPD-containing samples by the
VSV plaques
in

formed in

factor which would make

the presence of PPD equal

formed in

the expected number of

to the number formed by VSV

the absence of PPD.
As part of the last described experiment,

lymphocytes

from the same group of

animals were

purified macrophages and
tested for their ability to

produce interferon.

It appeared that each type of cell produced

interferon, but

there was no difference in the responsiveness

that

whether the cells came from sensitized animals or controls.

some
to PPD

This was also

true for lymphocyte preparations cultured with or without PPD for 96 hours.
Since each cell type alone
response observed in
experiment was

done.

did not appear capable of producing the

the crude exudate preparations,
Macrophages and lymphocytes,

manner, were recombined:

the following

prepared in the usual

sensitized lymphocytes with sensitized macrophages,

sensitized lymphocytes with normal macrophages, normal lymphocytes with
sensitized macrophages,

and normal lymphocytes with normal macrophages.

These were then incubated with or without PPD and the medium was assayed
for interferon.

The results,

summarized in Table 3,

suggest

that,

in

the

presence of PPD,

sensitized lymphocytes with either tuberculin-sensitized

or normal macrophages produce more interferon than these cells in the
absence of PPD.

The results of

the footpad test done on litter mates of

the animals used in the experiment

B.

are shown in Table 1.

INTERFERON PRODUCTION BY CELLS FROM CV-IMMUNIZED ANIMALS
The major portion of the experiments performed during the course of

this study were done before the PPD experiments

and were attempts

to confirm

.
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and extend

the work reported by Glasgow with CV immune cells.

the use of a variety of immunization routes,

cell collection techniques,

and cell culture conditions, none of the experiments
that cells

from animals

tried were:

from non-immune

animals.

Experimental

immunization by the intraperitoneal or intradermal

routes with or without an oil adjuvant;
exudates

resulted in evidence

immunized with CV produced more interferon when

exposed to CV in vitro than did cells
protocols

In spite of

collection of uninduced peritoneal

or exudates induced for 24 hours with trypticase soy broth;

culture

with either heat-inactivated fetal calf serum or heat-inactivated calf serum;
and culture with or without
experiments

antibiotics.

Except where noted,

to be described followed the protocol as outlined

the few
in Materials

and Methods.
Early experiments
of virus

(Table 4)

showed that only very high multiplicities

induced interferon production in vitro,

whether the cells came

from animals immunized with CV or control animals which had received intra¬
peritoneal injections of baby mouse brain

(BMB).

A typical result from an experiment in which no antibiotics were
used in the interferon preparations is seen in Table 5, which also shows
transformation of raw data into averages

and percentages.

The results

the

fail

to show any difference in plaque reduction caused by medium from CV cells
exposed

to CV when compared to medium from BMB cells exposed to CV.
Of interest in

these experiments was

preparations of macrophages
or control animals,

and cultured

which depressed VSV plaque
culture fluids

and lymphocytes,

obtained either

in vitro with CV,

formation

from uninfected

the observation that the purified

cells

(Table 6).

It

from CV immune

produced a substance
should be noted that

greatly increased the number of plaques

.
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formed by a standard amount of VSV.
VSV on cells

Using the number of plaques

treated with these uninfected

100% number of plaques,

probit plots

formed by

culture media as the expected or

can be constructed which yield 50%

plaque-depressing dilution of the preparations

(Figure 3).

.
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DISCUSSION
The experimental work presented
peritoneal

cells

in this

thesis provides evidence

from animals with delayed hypersensitivity to PPD produce

an enhanced interferon response when exposed to PPD i_n vitro,
from control animals
were done
this

do not.

to ascertain

response.

and interferon

that

whereas cells

Cell separation and recombination experiments

the roles of macrophages and lymphocytes in producing

Similar experiments using Chikungunya virus as immunogen
inducer failed to demonstrate any difference between cells

from immune and control animals.
Absent from the execution,

but not

the design,

of

these experiments

was a demonstration that the viral interference which was repeatedly
observed could be attributed
properties
used

allow it

to a substance whose biological and chemical

to be called an interferon.

in discussing the work described here refers

culture media to inhibit VSV plaque formation

Therefore,

interferon as

to the ability of certain

on L cells when

compared to

an appropriate control.
What were the appropriate controls?
Glasgow,

cells from immunized animals were compared with cells

immunized animals.
not valid.

Theoretically,

peritoneal exudate
to polyanions as

(AO).

described by Cohn

activation could include

reported by
from non-

such a comparison is probably

the different cell

(BCG)

has been shown to

types in guinea pig

Nonspecific "activation" of macrophages in response

must wonder how long such cells

(A6).

at least,

Immunization with a replicating antigen

alter the relative proportions of

Wagner

In the experiments

(10)

may also occur _in vivo,

and then one

remain "activated," and if such nonspecific

interferon production as suggested by Smith and

.
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To allow for

these possibilities,

experiments were from animals
primary aim of

control cells

a more ideal control would have been to immunize animals

response was specific for

the enhanced

In vitro interferon

the immunizing virus.

Control animals in the tuberculin experiments
however,

received injections of

a different heat-killed bacterium like Brucella or Listeria

would have been a better control.

The theoretical objections were somewhat

circumvented in these experiments by looking for differences
exposed

to different stimuli,
One difficulty with

that

to be

the latter approach was

interferon,

that

cells.

that it became obvious

The effect of PPD on VSV plaque

taken into account,

of more complete evidence

in the same cells

rather than for differences in different

titration controls were crucial.

formation had

The

to repeat Glasgow’s observation and,

with two different viruses and show that

Bayol F;

the virus

receiving injections of baby mouse brain.

the virus experiments was

had this been done,

for

as described above.

In the absence

the plaquing inhibitor observed was,

the possibility exists that

in fact,

the inhibitor acted indirectly by

preventing this plaquing enhancement caused by PPD.
The results of the PPD experiments suggest
produced when tuberculin-sensitized cells

that interferon is

are cultured in a manner similar

to that used in demonstrations of in vitro manifestations of delayed
hypersensitivity

(MIF,

CF,

etc.).

The report by Green et al,

interferon production by lymphocytes

from PPD-positive humans,

compared with MIF or CF production since
for four to ten days

these authors

showing
cannot be

cultured their cells

(27).

It was of interest to know whether a single cell

type could produce

the enhanced response or whether an interaction between lymphocytes and

.

28
macrophages was necessary.
sensitized lymphocyte is
for macrophages.

The recombination experiment

showed

that

the

the key cell but says nothing about the necessity

One experiment using purified cell populations suggested

that sensitized lymphocytes alone cannot produce the observed response.
Unfortunately,

great variability in the

titration

particular experiment prevented meaningful
can be made

from that experiment.

populations are still heterogeneous

controls

comparisons,

Furthermore,

for that

and no conclusion

the "purified" cell

enough to make one hesitate to draw any

conclusions about specific cells acting alone.

For example,

consider the

small amounts of interferon produced in the virus experiments by the
lymphocyte preparation

(Figure 3).

Does it

levels of production by the lymphocytes or

come

from low but

detectable

from the 5% contaminating

macrophages which are good interferon producers?

This

type of problem

could be approached by mixing different proportions of "macrophages" and
"lymphocytes."
With regard to controls

for the virus experiments,

acidified calf serum increased the number of plaques
amount of VSV.

However,

it was

found

that

formed by a standard

all culture media contained serum and this

factor

should not,

therefore, have influenced comparison of preparations.

other hand,

the influence of acidified CV on VSV plaquing was not determined

and,

in retrospect,

On

the

this would have been a desirable control.

The failure of the virus experiments
work reported by Glasgow is
differences in virus strain,

rather

described here to confirm the

typical of

cell clone,

interferon work.

Small

or animal species often greatly

influence interferon production and assay.

The animals and cells used in

the present research may differ slightly from those used by Glasgow;

.
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neither work serologically confirmed the identity of the virus used.
Glasgow,

himself,

has been unable to repeat his experiment using different

viruses,

but reports that a Japanese group successfully

experiment using a virus with which he was unsuccessful
and Mims

reported

that

repeated
(24).

the

Subrahmanyan

they were unable to confirm Glasgow's experiment,

but their experimental design was significantly different from his

(48).

Using an assay system in which the interferon-producing ability of individual
spleen cells

could be assayed,

suggested that cells

Osborn reported preliminary results which

from immune animals were better producers of interferon

when challenged with the homologous virus than were non-immune cells
Although the experimental results
allow generalizations
production,

described in this

concerning delayed hypersensitivity,

and recovery from viral infections,

(41).

thesis do not
interferon

they are suggestive enough

to warrant a reevaluation of some heretofore puzzling experimental results.
Stineberger and Rights

found

that vaccinia replicated far less well in

freshly explanted spleen cells
rabbits

(47).

from vaccinated than

from nonvaccinated

The difference was specific for vaccinia,

with kidney cells,

and could not be demonstrated

first cultured for seven days.

Flick and Pincus

if

was not observed

the spleen cells were

showed

that

rabbits

tolerant to vaccinia develop generalized fatal vaccinia and do not produce
the usual local vaccinia lesions

(18).

They suggested that delayed hyper¬

sensitivity was important in lesion formation and in protection against
generalized vaccinia.

Is it possible

that localized delayed hypersensitivity

reactions induce interferon production which is instrumental

in localizing

and inhibiting the virus?
Turk et al sensitized guinea pigs with ultraviolet

inactivated

.
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vaccinia and challenged them with live vaccinia at a time
there was no circulating antibody to vaccinia
were

then excised and

titered for vaccinia.

challenge,

there was

animals as

compared to immunized animals.

(49).
At 48,

The skin test sites
but not 24 hours after

a ten fold greater amount of virus

Mycobacterium tuberculosis

(five days) when

in non-immunized

Animals sensitized with

and challenged with a mixture of PPD and vaccinia

showed a "small but significant" decrease in vaccinia replication as
compared
Because

to MT sensitized animals challenged with vaccinia but no PPD.
the immunologically nonspecific or unrelated tuberculin reaction

inhibited vaccinia multiplication nearly as well as
reaction in vaccinated animals,

the postulated specific

the authors

concluded that delayed hyper¬

sensitivity does not play an important part

in the resolution of vaccinia

infections.

Had these authors known that delayed hypersensitivity reactions

to PPD could

result

in interferon production,

they might have interpreted

their results as showing that delayed hypersensitivity to viruses inhibits
virus multiplication and that

this effect is mediated by increased interferon

production at the reaction site.

.
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SUMMARY
The Importance of interferon in the recovery from viral infections
cannot be denied.
data,

Yet clinical observations, as well as some experimental

suggest that the ability to develop delayed hypersensitivity reactions

may also play a role in the normal recovery process.

The mechanisms whereby

interferon and delayed hypersensitivity reactions influence the outcome of
viral infections may be entirely distinct, or they may be related.
Experimental data reported in this thesis provide a link between the two and
suggest a mechanism that would explain the role of delayed hypersensitivity.
The data presented show that peritoneal cells from animals exhibiting
delayed hypersensitivity to PPD produce more interferon when cultured
in vitro with PPD than do cells from nonsensitized animals.

This result

appears to require the presence of both lymphocytes and macrophages.

Cell

separation and recombination experiments show that increased interferon
production occurs only when the lymphocytes are obtained from sensitized
animals, but that the macrophages may be obtained from either sensitized or
nonsensitized animals.

Attempts to show enhanced interferon production by

cells from virus-sensitized animals exposed to the sensitizing virus were
unsuccessful.

Several experiments in the literature are reappraised in view

of the possibility that interferon production as a manifestation of delayed
hypersensitivity can influence viral infections.

Table 1
FOOTPAD TEST

Sensitizing
Agent
MT*

Challenge
PPD

Largest

Average

% Increase

Dorsal-Ventral

Dorsal-Ventral

Over Diluent

Diameter

Diameter

Control

(mm,)

4.1
4.0
3.5
3.3

2.8
MT

Diluent

3.54

37.4

2.8
2.7

2.6
2.5
2.5
PPD

2.62

2.9

2.8
2.7
2.7
2.7
BF

Diluent

6.2

2.76

2.7

2.6
2.6
2.6
2.5

2.60

Footpad measurements were made 24 hours after challenge and 11 days
sensitization.

*Myobacterium tuberculosis
**Bayol F

after

Table 2

EFFECT OF PPD ON INTERFERON PRODUCTION BY CRUDE PERITONEAL CELLS
FROM TUBERCULIN SENSITIZED AND CONTROL ANIMALS

Dilution of Culture

Sensitizing

In Vitro

Avg.
of

Agent

Challenge

Plaques*

PPD

MT
MT

52

Diluent

BF

PPD

BF

Diluent

Cells

1:20

1:10

1:5
In Vivo

Supernatant

No.

± 3.0,

81 ± 9.41

Avg.
of

p**

Avg.
of

No.

Plaques

70 ± 5.7,

<0.01

95 ± 8.3*
82 ± 2.3,

77 ± 4.2,
<0.8
74 ± 7.81

89 ± 9.3*

Plaques

P

<0.02

<0.3

No.
P

84 ± 2.5,
105 ± 5.0*
97 ± 4.5,
105 ±

7.8*

<0.001

<0.5

from animals sensitized ten days before 24 hour _in vitro challenge.

Plaques counted 48 hours after L cells had been treated with supernatants

and

infected with VSV.

MT - Mycobacterium tuberculosis
BF - Bayol F

*From 9 plates

for each dilution;

samples ± standard error of

triplicate determinations

of three identical

the mean.
X!-x2

**From Student's jt test,

where

t =

(xi-Xi)

2

+ (x2-x2)

2

ni+n2-2
(Raw data for

this

calculation were corrected as discussed in Results.)

VSV in presence of PPD produced 119 plaques.
VSV in absence of PPD produced 110 plaques.

1

T

Table 3

INTERFERON PRODUCTION BY RECOMBINATIONS OF SENSITIZED AND NORMAL CELLS

Dilution of

Culture Supernatant

Sensitizing
Lymphs Macros

In Vitro
Challenge

Avg.
of

No.

Plaques

1:20

1:10

1:5

In Vivo

p

Avg. No.
of
Plaques

p

Avg. No.
of
Plaques

p

MT

MT

PPD

MT

MT

Diluent

14 +
2'9} <0.3
18 + 2.4;

14 + !.!
19 + 1.9

<0.03

17 + 1.7
28 + 2.4

<0.01

MT
MT

BF
BF

PPD
Diluent

10 +
18 +

3.5

22

+ 5.6,
21 + 2.2"’

<0.3

12 + 2.0
23 + 1.8

<0.01

BF

MT

PPD

!.4

MT

Diluent

17 + 2.4,
21 + 2.1s

<0.8

18 +
21 +

2.0

BF

17 +
13 +

<0.3

BF

BF

PPD

<0.2

20 +
13 +

2.7

BF

BF

Abbreviations

Diluent

12
15

1.3

2.1s

<0.001

<0.2

+ 1.8
<0.5
+ 2.8;

and calculations are the

same as

VSV in the presence of PPD produced 35 plaques.
VSV in the absence of PPD produced 27 plaques.

12

+

16 +

l.U
2.6s

for Table 2.

1.1

1.7

<0.1

Table 4

INTERFERON PRODUCTION RELATED TO AMOUNT OF VIRUS USED FOR INDUCTION

Concentration
Cells

Cells =

of Virus

Average

Added

of Plaq

CV*

10'1

148

CV

io“2

170

CV

10~3

224

BMB**

10-1

153

BMB

io"2

151

BMB

io"3

199

crude peritoneal cells

Vesicular stomatitis virus

*Chikungunya Virus
**Baby Mouse Brain

from animals

test dose =

immunized with either CV or BMB.

198 ± 30 PFU.
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Footnotes

INTERFERON

PRODUCTION

BY

CV-IMMUNE

AND

CONTROL

CELLS

S'?

Footnotes

for Table 5

*Crude peritoneal exudate cells from CV or BMB immunized animals
24 hours with CV

incubated

(10~*).

Plaques counted 40 hours after L cells had been treated with supernatants
and infected with VSV.
**Average plaques

for combined samples of each cell type expressed

error of the mean of

the nine

(or six)

determinations at each dilution.

Percentages are based on the number of plaques
on untreated L cells = 35 plaques.

± standard

formed by the test dose of VSV

Table 6

INTERFERON PRODUCTION BY MACROPHAGES AND LYMPHOCYTES

Interferon Dilution
1:7
Avg.
In Vivo
Sensitization

Cells

1:14
Avg. No.

Av g.

In Vitro

of

of

of

Challenge

Plaques

Plaques

Plaques

CV

Macros

CV

CV

Macros

BMB

BMB

Macros

CV

No.

1:28

6

16

36

141

141

143

CV

6

17

34

Lymphs

CV

72

95

109

CV

Lymphs

BMB

110

108

BMB

Lymphs

CV

53

85

No.

148*
116

Cells from animals hypersensitized eight weeks before 24 hour _in_ vitro
challenge.
Plaques counted 40 hours after L cells had been treated with supernatants
and infected with VSV.
Dose of VSV used in

titration was

39 PFU.

*This average was not statistically significantly different

from the

averages at the other two dilutions; therefore, in calculating the
percentages used in plotting the data, the average of the three
dilutions was used.

Figure JL

PLAQUE INHIBITION BY MEDIA FROM THE INCUBATION

Percentage of Expected Plaques

OF MYCOBACTERIUM SENSITIZED CELLS WITH AND WITHOUT PPD

(Dilution of Culture Supernatant)
L cells pretreated for 24 hours with various media.
VSV plaques

counted 48 hours after cells

infected.

x medium from the 24 hour incubation of sensitized peritoneal cells
with PPD.
o medium from the 24 hour incubation of sensitized peritoneal
without PPD.
Points plotted ± one standard of the mean.

cells

Figure 2

PLAQUE INHIBITION BY MEDIA FROM THE
INCUBATION OF NORMAL CELLS WITH AND WITHOUT PPD

L cells pretreated for 24 hours with various media.
VSV plaques

counted 48 hours after cells

infected.

x medium from the 24 hour incubation of normal peritoneal cells
with PPD.
o medium from the 24 hour incubation of normal peritoneal cells
without PPD.
Points plotted ± one

standard error of the mean.

Figure 3

PLAQUE INHIBITION BY MEDIA FROM THE INCUBATION
OF MACROPHAGES OR LYMPHOCYTES WITH CHIKUNGUNYA VIRUS

(Dilution of Culture Supernatant)-^
L cells pretreated for five hours with various media.
VSV plaques
.

counted 48 hours

after cells

infected.

medium from the 24 hour incubation of CV sensitized macrophages with CV.

o medium from the 24 hour incubation of BMB sensitized macrophages with CV.
x medium from the 24 hour incubation of CV sensitized lymphocytes with CV.
A medium from the 24 hour incubation of BMB sensitized lymphocytes with CV.

APPENDIX

MEDIA
A.

DILUENT
Medium 199 with Earles base
2% calf serum

(Flow Laboratories)

100 units/ml.

potassium penicillin G

100 yg./ml.

B.

(Grand Island Biological Co.)

streptomycin sulfate

(E.R.

Squibb & Sons)

(Eli Lilly & Co.)

CULTURE MEDIA
_1.

_L Cell Growth Medium
Minimum Essential Medium

(Eagle's) with Earles base

(Grand Island

Biological Co.)
10% calf serum
100 units/ml.
100 yg./ml.

2_.

potassium penicillin G

streptomycin sulfate

Peritoneal Exudate Harvesting Medium
Medium 199 with Earles base cnr Roswell Park Memorial Institute
Medium 1640

(Microbiological Associates,

Inc.)

20% fetal calf serum heat inactivated for 30 min.

at 56°C.

Island Biological Co.)
10 units/ml.

sodium heparin

100 units/ml.
100 yg./ml.

3_.

(Organon,

Inc.)

potassium penicillin G

streptomycin sulfate

Peritoneal Exudate Maintenance Medium
Roswell Park Memorial Institute Medium 1640
20% fetal calf serum heat inactivated for 30 min.
100 units/ml.
100 yg./ml.

potassium penicillin G

streptomycin sulfate

at 56°C.

(Grand

APPENDIX

4_.

(Continued)

First Agar Overlay
(a) Medium 199 with Earles base -2X
4% calf serum

200

units/ml.

200 yg./ml.

Cb) 2

gm.

5_.

2

(Oxoid)

distilled water

Warm solution

solutions

streptomycin sulfate

Ionagar No.

100 ml.

solution

potassium penicillin G

(b)

(a)

to 37°C.

to 56°C.

(a)

and

(b)

in water bath.

in water bath.

Cool freshly autoclaved

Mix equal volumes of

and use within 20 minutes.

Second Agar Overlay
Prepare as first agar overlay except that solution
contains 67 yg./ml.

neutral red

(a)

also

(National Aniline Division,

Allied Chemical)

Note:

Minimum Essential Medium with Earles base. Medium 199 with Earles
base,

and Medium 199 with Earles base -2X were prepared from

pre-mixed powders

(Grand Island Biological Co.)
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